Indications and uses
0.9% Sodium Chloride Irrigation is indicated for all general irrigation, washing, rinsing and dilution purposes which permit use of a sterile, nonpyrogenic electrolyte solution.
0.9% Sodium Chloride Irrigation is indicated for all general irrigation, washing, rinsing and dilution purposes which permit use of a sterile, nonpyrogenic electrolyte solution.
As required for irrigation. When used as a diluent, or vehicle for other drugs, the drug manufacturer's recommendations should be followed. Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store. Solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and contain...
Each 100 mL contains:
Sodium Chloride, USP 0.9 g; Water for Injection, USP qs pH adjusted with Hydrochloric Acid, NF
pH: 5.75 (4.50-7.00)
Calculated Osmolarity: 308 mOsmol/liter
Concentration of Electrolytes (mEq/liter): Sodium 154; Chloride 154
0.9% Sodium Chloride Irrigation, USP is sterile, nonpyrogenic, isotonic and contains no bacteriostatic or antimicrobial agents.
The formula of the active ingredient is:
Ingredient | Molecular Formula | Molecular Weight |
Sodium Chloride, USP | NaCl | 58.44 |
The flexible plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers. The solution contact layer is a copolymer of ethylene and propylene. The container is nontoxic and biologically inert.
The container-solution unit is a closed system and is not dependent upon entry of external air during administration.
Not made with natural rubber latex, PVC or DEHP.
0.9% Sodium Chloride Irrigation is utilized for a variety of clinical indications such as sterile irrigation of body cavities, tissues or wounds, indwelling urethral catheters, surgical drainage tubes, and for washing, rinsing or soaking surgical dressings, instruments and laboratory specimens. It also serves as a diluent or vehicle for drugs used for irrigation or other pharmaceutical preparations.
0.9% Sodium Chloride Irrigation provides an isotonic saline irrigation identical in composition with 0.9% Sodium Chloride Injection (normal saline).
Physiological irrigation solutions are considered generally compatible with living tissues and organs.
Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.
Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.
0.9% Sodium Chloride Irrigation is indicated for all general irrigation, washing, rinsing and dilution purposes which permit use of a sterile, nonpyrogenic electrolyte solution.
0.9% Sodium Chloride Irrigation is not for injection by usual parenteral routes.
An electrolyte solution should not be used for irrigation during electrosurgical procedures.
FOR IRRIGATION ONLY. NOT FOR INJECTION.
Irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus, irrigation solutions must be regarded as systemic drugs.
Absorption of large amounts can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.
The risk of dilutional states is inversely proportional to the electrolyte concentrations of the administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration.
Do not warm container above 140°F (60°C).
After opening container, its contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation.
Discard unused portion of irrigating solution since it contains no preservatives.
Use aseptic technique when preparing and administering sterile irrigation solutions. Use only if solution is clear and container and seal are intact.
Do not use for irrigation that may result in absorption of large amounts of fluid into the blood.
Caution should be observed when the solution is used for continuous irrigation or allowed to “dwell” inside body cavities because of possible absorption into the blood stream and the production of circulatory overload.
When used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or repeat procedure. For repeated irrigations of urethral catheters, a separate container should be used for each patient.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance after prolonged irrigation, when fluid absorption is suspected, or whenever the condition of the patient warrants such evaluation.
Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic technique. Mix thoroughly. Do not store.
Studies with 0.9% Sodium Chloride Irrigation have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.
Animal reproduction studies have not been conducted with 0.9% Sodium Chloride Irrigation. It is also not known whether 0.9% Sodium Chloride Irrigation can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 0.9% Sodium Chloride Irrigation should be given to a pregnant woman only if clearly needed.
Safety and effectiveness of 0.9% Sodium Chloride Irrigation during labor and delivery have not been established. Caution should be exercised, and the fluid balance, glucose and electrolyte concentrations, and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when 0.9% Sodium Chloride Irrigation is administered to a nursing woman.
The safety and effectiveness of 0.9% Sodium Chloride Irrigation in pediatric patients have not been established. Its limited use in pediatric patients has been inadequate to fully define proper dosage and limitations for use.
Clinical studies of 0.9% Sodium Chloride Irrigation did not include a sufficient number of patients age 65 years and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Frequent laboratory determinations and clinical evaluations are recommended to monitor changes in blood glucose, electrolyte concentrations, and renal function.
Possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes can be minimized when proper procedures are followed. Displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. Excessive volume or pressure during irrigation of closed cavities may cause undue distension or disruption of tissues. Accidental contamination from careless technique may transmit infection.
If an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
In the event of overhydration or solute overload, reevaluate the patient's condition, and institute appropriate corrective treatment. Intravascular volume overload may respond to hemodialysis. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.
As required for irrigation.
When used as a diluent, or vehicle for other drugs, the drug manufacturer's recommendations should be followed.
Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.
Solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permits.
0.9% Sodium Chloride Irrigation, USP is supplied sterile and nonpyrogenic in single-dose flexible plastic containers.
Product Code | Unit of Sale | Each |
502010 | NDC 65219-502-10 | NDC 65219-502-01 |
504020 | NDC 65219-504-20 | NDC 65219-504-02 |
506030 | NDC 65219-506-30 | NDC 65219-506-03 |
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]; however, brief exposure up to 40°C (104°F) does not adversely affect the product.
Do not warm container above 140°F (60°C).
Not for Injection. Not for use with pressurized irrigation systems.
Check solution container composition, lot number, and expiry date.
Irrigation solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Do not use if the solution is cloudy or precipitate is present.
Check the solution container for leaks by squeezing firmly. If leaks are found, discard.
The intact port cap provides visual tamper evidence. Do not use if port cap is prematurely removed. Maintain strict aseptic technique during handling.
To Add Medication:
Preparation for Administration
Manufactured for:

Lake Zurich, IL 60047
Made in Germany
www.fresenius-kabi.com/us
451818A
Revised: January 2025
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | Code 128 | (01)00365219502012 | GTIN-14: 00365219502012 GTIN-12: 365219502012 UPC-A: 365219502012 EAN-13: 0365219502012 GTIN storage (14 digits): 00365219502012 | sod17-0003-03.jpg |
| Data code | Code 128 | (01)00150719504023 | sod17-0003-05.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65219-502-01 | Sodium chloride | 1000 mL in 1 BAG | INJECTION, SOLUTION | 1000 | 6 | |
| 65219-502-10 | Sodium chloride | 6 in 1 CASE | INJECTION, SOLUTION | 6 | 6 | |
| 65219-504-02 | Sodium chloride | 2000 mL in 1 BAG | INJECTION, SOLUTION | 2000 | 6 | |
| 65219-504-20 | Sodium chloride | 5 in 1 CASE | INJECTION, SOLUTION | 5 | 6 | |
| 65219-506-03 | Sodium chloride | 3000 mL in 1 BAG | INJECTION, SOLUTION | 3000 | 6 | |
| 65219-506-30 | Sodium chloride | 4 in 1 CASE | INJECTION, SOLUTION | 4 | 6 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65219-506-03 | ML - Milliliter | 65219-506 | 13db7450-6dff-42d7-b90b-ceca8ef44427 | 1 | 2025-03-04 |
| 65219-506-30 | ML - Milliliter | 65219-506 | 3d29d4c3-5aaf-4c2c-8f8f-9ed462336eb8 | 1 | 2025-03-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 65219-502 | 65219-502-01, 65219-502-10 |
| 65219-504 | 65219-504-02, 65219-504-20 |
| 65219-506 | 65219-506-03, 65219-506-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| WATER | 059QF0KO0R | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| WATER | 059QF0KO0R | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| WATER | 059QF0KO0R | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | SODIUM CHLORIDE | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 |
| Application-product | TE code |
|---|---|
| A213688-001 | AT |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | 301d65b070ca… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213688-001 | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 900MG/100ML | SOLUTION / IRRIGATION | AT | 2024-06-24 | a50c72e98297… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213688-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A213688-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A213688-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213688-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A213688-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213688-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213688-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213688-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213688-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213688-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213688-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A213688-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213688-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213688-001 | AT | 1 | 301d65b070ca… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213688-001 | AT | 1 | a50c72e98297… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | ce0c8c6f-734a-400f-9b60-a3b1e263f25f | 2025-11-18 | Warnings, Adverse reactions | 65219-506-30 65219-502-01 65219-506-03 65219-504-20 65219-504-02 65219-502-10 65219-502 65219-506 65219-504 65219050603 65219050402 65219050201 65219050210 65219050420 65219050630 53843388-e3bc-4344-87aa-b345680ec27b ce0c8c6f-734a-400f-9b60-a3b1e263f25f |
Adverse event summaries are temporarily unavailable. Other product information remains available.